Type 1 diabetes and oral agents

Type 1 diabetes and oral agents

Type 1 diabetes and oral agents (#204)

Jenny E Gunton ¹ ²

University of Sydney, Westmead, NSW, Australia
The Westmead Millennium Institute for Medical Research, The University of Sydney, Westmead Hospital, Division of Medicine, The Garvan Institute of Medical Research, Sydney

Cure of type 1 diabetes can be only achieved in a small fraction of individuals by whole pancreas transplantation or islet transplantation. In the majority, however, best-possible glucose control remains the therapeutic goal. All people with current type 1 diabetes require insulin, however, there are some oral medications which can be used to improve glucose control. These include metformin and SGLT2 inhibitors.

In this session, the evidence for efficacy of oral agents in type 1 diabetes will be discussed, as well as their potential dangers.

Authors contributing to this presentation.

Gunton, J.E

Professor Jenny Gunton heads the Centre for Diabetes, Obesity and Endocrinology Research (CDOER) and Westmead Institute for Medical Research (WIMR). She is Chair of Medicine at Westmead Hospital and a clinical endocrinologist / diabetologist. In 2012 she became the President of the Australian Diabetes Society and in 2014 became Chair of Medicine at Sydney University, Westmead Hospital. Her lab moved to the new WIMR in late 2014. Her research interests include diabetes, obesity, and vitamin D. She is particularly interested in the intersection of transcription factors and their regulation by nutrients.

Type 1 diabetes and oral agents (#204)

Add notes

Gunton, J.E

Login